Literature DB >> 6152147

Murein hydrolase (N-acetyl-muramyl-L-alanine amidase) in human serum.

S Mollner, V Braun.   

Abstract

An enzyme was identified in human serum which unlike lysozyme cleaved the amide bond between N-acetyl-muramic acid and L-alanine of the peptide side chain of the rigid layer (murein) of Escherichia coli. The N-acetyl-muramyl-L-alanine amidase released all of the peptide side chains including those to which the lipoprotein is bound. A portion of the peptide side chains of the Micrococcus lysodeikticus murein was also hydrolysed from the polysaccharide chains. E. coli, M. lysodeikticus, Bacillus subtilis and Staphylococcus aureus were not killed by the amidase. Treatment of E. coli with EDTA or osmotic shock rendered the cells sensitive to the amidase and they were killed. Possible biological functions of the amidase are discussed. The enzyme was separated from lysozyme in human serum. Gel permeation chromatography indicated a molecular weight of the active enzyme of 82,000 while gel electrophoresis in the presence of sodium dodecyl sulfate revealed a molecular weight of 75,000. Thus, the enzyme probably consists of a single polypeptide chain. Incubation with neuraminidase rendered the amidase more basic suggesting the release of sialic acid residues. The modified glycoprotein disclosed an increased activity to murein. Enzyme activity was inhibited by p-chloromercuribenzene sulfonate and ethyleneglycol-bis(2-aminomethyl) tetraacetate (EGTA) at 1 and 0.2 mM concentration, respectively, whereas EDTA up to 5 mM was without effect. The amidase was also inactivated by agents that reduce disulfide bridges.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152147     DOI: 10.1007/BF00454921

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  22 in total

1.  Novel type of murein transglycosylase in Escherichia coli.

Authors:  J V Höltje; D Mirelman; N Sharon; U Schwarz
Journal:  J Bacteriol       Date:  1975-12       Impact factor: 3.490

2.  Escherichia coli murein-DD-endopeptidase insensitive to beta-lactam antibiotics.

Authors:  W Keck; U Schwarz
Journal:  J Bacteriol       Date:  1979-09       Impact factor: 3.490

3.  Bypass of receptor-mediated resistance to colicin E3 in Escherichia coli K-12.

Authors:  M Tilby; I Hindennach; U Henning
Journal:  J Bacteriol       Date:  1978-12       Impact factor: 3.490

4.  Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure.

Authors:  V Braun; K Rehn
Journal:  Eur J Biochem       Date:  1969-10

5.  Envelope-bound N-acetylmuramyl-L-alanine amidase of Escherichia coli K 12. Purification and properties of the enzyme.

Authors:  J van Heijenoort; C Parquet; B Flouret; Y van Heijenoort
Journal:  Eur J Biochem       Date:  1975-10-15

6.  Penetration of colicin M into cells of Escherichia coli.

Authors:  V Braun; J Frenz; K Hantke; K Schaller
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

7.  Micrococcus lysodeikticus: a new type of cross-linkage of the murein.

Authors:  K H Schleifer; O Kandler
Journal:  Biochem Biophys Res Commun       Date:  1967-09-27       Impact factor: 3.575

8.  Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum.

Authors:  Z Valinger; B Ladesić; J Tomasić
Journal:  Biochim Biophys Acta       Date:  1982-02-04

9.  Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes.

Authors:  R S Rosenthal; W J Folkening; D R Miller; S C Swim
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock.

Authors:  C A Roten; D Karamata
Journal:  Experientia       Date:  1992-10-15

2.  Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids.

Authors:  A Fox; K Fox; B Christensson; D Harrelson; M Krahmer
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Peptidoglycan recognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in keratinocytes by bacteria through the p38 kinase pathway.

Authors:  Haitao Wang; Dipika Gupta; Xinna Li; Roman Dziarski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Human serum triggers antibiotic tolerance in Staphylococcus aureus.

Authors:  Elizabeth V K Ledger; Stéphane Mesnage; Andrew M Edwards
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

Review 5.  Peptidoglycan at its peaks: how chromatographic analyses can reveal bacterial cell wall structure and assembly.

Authors:  Samantha M Desmarais; Miguel A De Pedro; Felipe Cava; Kerwyn Casey Huang
Journal:  Mol Microbiol       Date:  2013-06-03       Impact factor: 3.501

6.  Degradation of muramyl dipeptide by mammalian serum.

Authors:  J Harrison; A Fox
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits.

Authors:  A Fox; K Fox
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.